ATE421571T1 - Neues protein tab2 - Google Patents

Neues protein tab2

Info

Publication number
ATE421571T1
ATE421571T1 AT99974205T AT99974205T ATE421571T1 AT E421571 T1 ATE421571 T1 AT E421571T1 AT 99974205 T AT99974205 T AT 99974205T AT 99974205 T AT99974205 T AT 99974205T AT E421571 T1 ATE421571 T1 AT E421571T1
Authority
AT
Austria
Prior art keywords
tab2
signal transduction
new protein
tak1
activation
Prior art date
Application number
AT99974205T
Other languages
English (en)
Inventor
Kunihiro Matsumoto
Original Assignee
Kunihiro Matsumoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunihiro Matsumoto filed Critical Kunihiro Matsumoto
Application granted granted Critical
Publication of ATE421571T1 publication Critical patent/ATE421571T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869Interleukin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/20Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99974205T 1999-11-19 1999-11-19 Neues protein tab2 ATE421571T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1999/006466 WO2001038527A1 (en) 1999-11-19 1999-11-19 Novel protein tab2

Publications (1)

Publication Number Publication Date
ATE421571T1 true ATE421571T1 (de) 2009-02-15

Family

ID=14237333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99974205T ATE421571T1 (de) 1999-11-19 1999-11-19 Neues protein tab2

Country Status (6)

Country Link
US (3) US7153664B2 (de)
EP (1) EP1234880B9 (de)
JP (1) JP4488665B2 (de)
AT (1) ATE421571T1 (de)
DE (1) DE69940359D1 (de)
WO (1) WO2001038527A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE421571T1 (de) 1999-11-19 2009-02-15 Kunihiro Matsumoto Neues protein tab2
WO2004022599A1 (ja) * 2002-08-22 2004-03-18 Peptide Door Co.,Ltd. 融合抗体及びその作成方法
GB0306071D0 (en) * 2003-03-17 2003-04-23 Novartis Ag Organic compounds
EP1608755B1 (de) * 2003-04-01 2012-10-17 Helmholtz-Zentrum für Infektionsforschung GmbH Tak1-vermittelte hemmung der osteogenese
US8765370B2 (en) * 2009-06-11 2014-07-01 Scinopharm Taiwan, Ltd Inhibition-based high-throughput screen strategy for cell clones
KR101595318B1 (ko) 2014-03-25 2016-02-18 한국알프스 주식회사 다채널 led 조명기구에서 채널간의 전류편차 최소화 제어방법
WO2016011155A1 (en) 2014-07-15 2016-01-21 Kapre Subhash V Genetically detoxified pertussis that maintains intrinsic adjuvant activity
CN110201418B (zh) * 2019-05-09 2020-10-27 西安交通大学 一种基于固定化SNAP-tag融合蛋白的细胞膜色谱柱及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837703A (en) * 1993-03-31 1998-11-17 Cell Therapeutics, Inc. Amino-alcohol substituted cyclic compounds
US5576423A (en) * 1994-12-02 1996-11-19 Schering Corporation Antibodies to the slam protein expressed on activated T cells
JP3907247B2 (ja) 1996-04-24 2007-04-18 中外製薬株式会社 Tab1蛋白質及びそれをコードするdna
ATE283356T1 (de) 1996-04-24 2004-12-15 Chugai Pharmaceutical Co Ltd Tab1 protein und dafür kodierende dna
ATE421571T1 (de) 1999-11-19 2009-02-15 Kunihiro Matsumoto Neues protein tab2

Also Published As

Publication number Publication date
US20120064084A1 (en) 2012-03-15
US20030040050A1 (en) 2003-02-27
US20070161565A1 (en) 2007-07-12
US7153664B2 (en) 2006-12-26
DE69940359D1 (de) 2009-03-12
JP4488665B2 (ja) 2010-06-23
WO2001038527A1 (en) 2001-05-31
EP1234880B9 (de) 2009-09-23
EP1234880A4 (de) 2004-03-31
US8058241B2 (en) 2011-11-15
EP1234880A1 (de) 2002-08-28
EP1234880B1 (de) 2009-01-21
US8491900B2 (en) 2013-07-23

Similar Documents

Publication Publication Date Title
ATE421571T1 (de) Neues protein tab2
DE69917469D1 (de) Pyrimidin derivate
BRPI0415433A (pt) derivados de n-[fenil (alquilpiperidin-2-il)metil] benzamida, seu preparo e sua aplicação em terapêutica
DZ3420A1 (fr) Combinaison d'herbicides avec des sulfonylurees speciales
WO1999067252A3 (en) Epothilone derivatives and their synthesis and use
HK1046687A1 (zh) 喹唑啉衍生物
DK1109812T3 (da) Pyrrolobenzodiazepiner
EP1288202A4 (de) N-acyltetrahydroisochinolin-derivate
ATE442364T1 (de) Kristalline form von linezolid
DE69226057D1 (de) Elektroakustischer Wandler vom Elektret-Typ
DK482088A (da) Anvendelse af 1,3,7-trisubstituerede purin-2,6-dion-forbindelser til fremstilling af et laegemiddel med interleukin-1-inhiberende virkning
DE60100393D1 (de) Drehwinkelsensor mit linearer Ausgangscharakteristik
DK1258167T3 (da) Akustisk transducer med forbedret akustisk dæmper
BR0307071A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
DE69609576D1 (de) Bioverfügbare kristalline Form des Cefuroxim-Axetils
DE60141875D1 (de) Messung des Ähnlichkeitsgrads der Stimme
DK0747392T3 (da) Dobbeltvirkende inhibitorer indeholdende 1,2-diazepiner
KR950704250A (ko) 소염제 및 항변성제로서의 신규한 치환된 아제티디논(New substituted azetidinones as anti―inflammatory and antidegenerative agents)
FI914855L (fi) Ekstrudoitavan eteeni-hydroksiakrylaatti-sekapolymeerin käyttö
DE69024727D1 (de) Kornverfeinerung des Zirkoniums mittels Silizium
EP1632484A4 (de) Thiadiazolinderivat
LV10448A (lv) Piperazinilkamparsulfoniloksitocina antagonista aizvietotie amidu atvasinajumi
HRP20090180T1 (en) Biotinylated hexadecasaccharides, pharmaceutical compositions and use thereof
WO2001002366A3 (en) Substituted isoquinoline derivatives and their use as inticonvulsants

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties